Skip to main content

Press Releases

November 16, 2017
Congresswoman Rosa DeLauro (CT-03) today released the following statement in response to the United States Department of Agriculture Food Safety Inspection Service’s (FSIS) recent audit of Brazil’s meat inspection system.
November 15, 2017
Our nation’s men and women in uniform deserve the best treatment possible, especially when it comes to their health.
November 15, 2017
“The Trump Administration’s immediate stay on collecting wage data from large companies via the EEO-1 form is an illegal attack on equal pay, plain and simple,” said DeLauro.
November 14, 2017
Congresswoman Rosa DeLauro (CT-03) led advocacy leaders and retail workers in a call for fairer workplace scheduling policies.
November 14, 2017
As negotiations begin to rewrite “borrower defense” rule to help defrauded students, DeLauro and Murray urge Secretary DeVos to open all meetings to the public.
Issues:Education
November 13, 2017
Congresswoman Rosa DeLauro (CT-03) today released the following statement in response to President Trump’s nomination of Alex Azar to serve as Secretary of the Department of Health and Human Services.
November 6, 2017
Congresswoman Rosa DeLauro (CT-03) today released the following statement celebrating the opening of the new rail line in Wallingford. A longtime supporter of improving Connecticut’s transportation systems, DeLauro fought for the more than $190 million in federal aid that helped fund the rail line.
November 3, 2017
Congresswoman Rosa DeLauro (CT-03) and Congressman Bobby Scott (VA-03) released the following statement in opposition to the Workflex in the 21st Century Act, which would exempt companies from state and local paid leave requirements under certain circumstances.
November 2, 2017
Congresswoman Rosa DeLauro (CT-03) released the following statement on the Congressional Republicans’ bill that would cut taxes for corporations, millionaires and billionaires while raising taxes on middle class families.
October 30, 2017
Congresswomen Rosa DeLauro (CT-03), Louise Slaughter (NY-25), and Jan Schakowsky (IL-09), sent a letter to Food and Drug Administration (FDA) Commissioner Scott Gottlieb requesting additional information regarding his decision to allow Essure to stay on the market.